Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- Resource Type
- Article
- Source
- In
The Journal of Allergy and Clinical Immunology January 2020 145(1):173-182 - Subject
- Language
- ISSN
- 0091-6749